News & Analysis on Clinical Trial Services & Contract Research And Development
As the waiting period for LabCorp and Covance to proceed with their integration ended late last month, both companies are now turning to the logistics of the merger and hiring Deloitte consultants to help.
The agency issued a warning letter and withdrew the GMP (Good Manufacturing Practice) certificate from Hyderabad, India-based Sri Krishna Pharmaceuticals for 10 GMP deviations found during an inspection at its Nacharam granulation plant in December.
Novacyl Wuxi Pharmaceutical has received a US FDA warning letter for failing to investigate the origin of metal particles found in drugs made at its paracetamol plant in China.
Parexel will see more business from its Big Pharma clients in 2015, even if Pfizer names a third CRO say analysts.
Gilead and AbbVie’s exclusive deals with payers CVS and Express Scripts could help cut the cost of the new class of treatments for America’s three million Hepatitis C sufferers.
More than a year since its creation, India’s Apex Committee is now calling for developers of cancer treatments approved without trials in India to monitor the first 500 patients to assess the drugs’ safety and efficacy.